A suitable drug structure for interaction with SARS‐CoV‐2 main protease between boceprevir, masitinib and rupintrivir; a molecular dynamics study

In recent years, more than 200 countries of the world have faced a health crisis due to the epidemiological disease of COVID-19 caused by the SARS-CoV-2 virus. It had a huge impact on the world economy and the global health sector. Researchers are studying the design and discovery of drugs that can...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoosefian, Mehdi, Dashti, Razieh, Mahani, Mohamad, Montazer, Leila, Mir, Amirabbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. on behalf of King Saud University. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246938/
https://www.ncbi.nlm.nih.gov/pubmed/37323221
http://dx.doi.org/10.1016/j.arabjc.2023.105051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246938/
https://www.ncbi.nlm.nih.gov/pubmed/37323221
http://dx.doi.org/10.1016/j.arabjc.2023.105051

Ejemplares similares